nodes	percent_of_prediction	percent_of_DWPC	metapath
Norethindrone—ALB—hematologic cancer	0.0777	0.512	CbGaD
Norethindrone—ABCB1—hematologic cancer	0.0742	0.488	CbGaD
Norethindrone—PGR—Betamethasone—hematologic cancer	0.029	0.0718	CbGbCtD
Norethindrone—Danazol—Prednisone—hematologic cancer	0.0206	0.0858	CrCrCtD
Norethindrone—Cortisone acetate—Prednisone—hematologic cancer	0.0174	0.0723	CrCrCtD
Norethindrone—Cortisone acetate—Prednisolone—hematologic cancer	0.017	0.0706	CrCrCtD
Norethindrone—PGR—Dexamethasone—hematologic cancer	0.0169	0.0418	CbGbCtD
Norethindrone—Fluoxymesterone—Dexamethasone—hematologic cancer	0.0167	0.0696	CrCrCtD
Norethindrone—Fluoxymesterone—Betamethasone—hematologic cancer	0.0167	0.0696	CrCrCtD
Norethindrone—Fluoxymesterone—Triamcinolone—hematologic cancer	0.0163	0.068	CrCrCtD
Norethindrone—Fluoxymesterone—Prednisolone—hematologic cancer	0.0151	0.063	CrCrCtD
Norethindrone—Progesterone—Prednisolone—hematologic cancer	0.0147	0.0613	CrCrCtD
Norethindrone—Methyltestosterone—Prednisone—hematologic cancer	0.0147	0.0613	CrCrCtD
Norethindrone—Methyltestosterone—Prednisolone—hematologic cancer	0.0144	0.0598	CrCrCtD
Norethindrone—Hydrocortisone—Dexamethasone—hematologic cancer	0.0133	0.0553	CrCrCtD
Norethindrone—Hydrocortisone—Betamethasone—hematologic cancer	0.0133	0.0553	CrCrCtD
Norethindrone—Hydrocortisone—Triamcinolone—hematologic cancer	0.013	0.054	CrCrCtD
Norethindrone—Testosterone—Prednisolone—hematologic cancer	0.0128	0.0532	CrCrCtD
Norethindrone—Hydrocortisone—Prednisone—hematologic cancer	0.0123	0.0512	CrCrCtD
Norethindrone—Hydrocortisone—Prednisolone—hematologic cancer	0.012	0.05	CrCrCtD
Norethindrone—ABCB1—Lenalidomide—hematologic cancer	0.0109	0.0269	CbGbCtD
Norethindrone—CYP3A7—Ifosfamide—hematologic cancer	0.0105	0.0259	CbGbCtD
Norethindrone—CYP3A7-CYP3A51P—Ifosfamide—hematologic cancer	0.0105	0.0259	CbGbCtD
Norethindrone—CYP3A7-CYP3A51P—Imatinib—hematologic cancer	0.01	0.0248	CbGbCtD
Norethindrone—CYP3A7—Imatinib—hematologic cancer	0.01	0.0248	CbGbCtD
Norethindrone—CYP3A5—Daunorubicin—hematologic cancer	0.0098	0.0242	CbGbCtD
Norethindrone—ALB—Imatinib—hematologic cancer	0.00934	0.0231	CbGbCtD
Norethindrone—CYP3A5—Thalidomide—hematologic cancer	0.00892	0.0221	CbGbCtD
Norethindrone—CYP3A5—Teniposide—hematologic cancer	0.00851	0.0211	CbGbCtD
Norethindrone—CYP2C19—Bortezomib—hematologic cancer	0.00826	0.0204	CbGbCtD
Norethindrone—CYP3A5—Ifosfamide—hematologic cancer	0.00785	0.0194	CbGbCtD
Norethindrone—PGR—ovarian follicle—hematologic cancer	0.00757	0.394	CbGeAlD
Norethindrone—CYP3A5—Imatinib—hematologic cancer	0.0075	0.0186	CbGbCtD
Norethindrone—CYP2C19—Thalidomide—hematologic cancer	0.0072	0.0178	CbGbCtD
Norethindrone—CYP2C19—Teniposide—hematologic cancer	0.00687	0.017	CbGbCtD
Norethindrone—CYP3A4—Bexarotene—hematologic cancer	0.00652	0.0161	CbGbCtD
Norethindrone—ABCB1—Daunorubicin—hematologic cancer	0.00638	0.0158	CbGbCtD
Norethindrone—CYP2C19—Ifosfamide—hematologic cancer	0.00634	0.0157	CbGbCtD
Norethindrone—CYP3A7-CYP3A51P—Irinotecan—hematologic cancer	0.00625	0.0155	CbGbCtD
Norethindrone—CYP3A7—Irinotecan—hematologic cancer	0.00625	0.0155	CbGbCtD
Norethindrone—ABCB1—Alitretinoin—hematologic cancer	0.00625	0.0155	CbGbCtD
Norethindrone—ALB—Prednisone—hematologic cancer	0.00615	0.0152	CbGbCtD
Norethindrone—CYP3A4—Lomustine—hematologic cancer	0.00606	0.015	CbGbCtD
Norethindrone—CYP3A4—Busulfan—hematologic cancer	0.00606	0.015	CbGbCtD
Norethindrone—CYP2C19—Imatinib—hematologic cancer	0.00605	0.015	CbGbCtD
Norethindrone—CYP3A5—Dasatinib—hematologic cancer	0.00603	0.0149	CbGbCtD
Norethindrone—ALB—Irinotecan—hematologic cancer	0.00583	0.0144	CbGbCtD
Norethindrone—CYP3A7-CYP3A51P—Vincristine—hematologic cancer	0.00546	0.0135	CbGbCtD
Norethindrone—CYP3A7—Vincristine—hematologic cancer	0.00546	0.0135	CbGbCtD
Norethindrone—CYP3A4—Thiotepa—hematologic cancer	0.0054	0.0134	CbGbCtD
Norethindrone—ABCB1—Imatinib—hematologic cancer	0.00488	0.0121	CbGbCtD
Norethindrone—CYP3A5—Irinotecan—hematologic cancer	0.00469	0.0116	CbGbCtD
Norethindrone—ABCB1—Nilotinib—hematologic cancer	0.00444	0.011	CbGbCtD
Norethindrone—ABCB1—Vinorelbine—hematologic cancer	0.0044	0.0109	CbGbCtD
Norethindrone—CYP3A4—Methoxsalen—hematologic cancer	0.0042	0.0104	CbGbCtD
Norethindrone—CYP3A7-CYP3A51P—Dexamethasone—hematologic cancer	0.00411	0.0102	CbGbCtD
Norethindrone—CYP3A7—Dexamethasone—hematologic cancer	0.00411	0.0102	CbGbCtD
Norethindrone—CYP3A5—Vincristine—hematologic cancer	0.0041	0.0101	CbGbCtD
Norethindrone—CYP3A4—Bortezomib—hematologic cancer	0.00399	0.00988	CbGbCtD
Norethindrone—CYP2C19—Prednisone—hematologic cancer	0.00399	0.00987	CbGbCtD
Norethindrone—ABCB1—Dasatinib—hematologic cancer	0.00392	0.00971	CbGbCtD
Norethindrone—ABCB1—Mitoxantrone—hematologic cancer	0.00387	0.00959	CbGbCtD
Norethindrone—CYP3A4—Daunorubicin—hematologic cancer	0.00382	0.00945	CbGbCtD
Norethindrone—CYP3A5—Etoposide—hematologic cancer	0.00375	0.00929	CbGbCtD
Norethindrone—ABCB1—Betamethasone—hematologic cancer	0.00345	0.00855	CbGbCtD
Norethindrone—ABCB1—Gemcitabine—hematologic cancer	0.00342	0.00847	CbGbCtD
Norethindrone—ABCB1—Prednisolone—hematologic cancer	0.00341	0.00843	CbGbCtD
Norethindrone—CYP3A4—Cytarabine—hematologic cancer	0.00337	0.00834	CbGbCtD
Norethindrone—CYP3A4—Teniposide—hematologic cancer	0.00332	0.00821	CbGbCtD
Norethindrone—ABCB1—Prednisone—hematologic cancer	0.00322	0.00796	CbGbCtD
Norethindrone—CYP3A5—Dexamethasone—hematologic cancer	0.00309	0.00764	CbGbCtD
Norethindrone—ALB—Methotrexate—hematologic cancer	0.00309	0.00764	CbGbCtD
Norethindrone—CYP3A4—Ifosfamide—hematologic cancer	0.00306	0.00758	CbGbCtD
Norethindrone—ABCB1—Irinotecan—hematologic cancer	0.00305	0.00755	CbGbCtD
Norethindrone—CYP3A4—Imatinib—hematologic cancer	0.00293	0.00724	CbGbCtD
Norethindrone—CYP3A4—Ruxolitinib—hematologic cancer	0.00276	0.00682	CbGbCtD
Norethindrone—ABCB1—Vinblastine—hematologic cancer	0.00271	0.00671	CbGbCtD
Norethindrone—ABCB1—Vincristine—hematologic cancer	0.00267	0.0066	CbGbCtD
Norethindrone—CYP3A4—Nilotinib—hematologic cancer	0.00266	0.00658	CbGbCtD
Norethindrone—CYP3A4—Vinorelbine—hematologic cancer	0.00264	0.00653	CbGbCtD
Norethindrone—CYP2C19—Dexamethasone—hematologic cancer	0.00249	0.00616	CbGbCtD
Norethindrone—ABCB1—Cisplatin—hematologic cancer	0.00249	0.00615	CbGbCtD
Norethindrone—ABCB1—Etoposide—hematologic cancer	0.00244	0.00605	CbGbCtD
Norethindrone—CYP3A4—Triamcinolone—hematologic cancer	0.00241	0.00597	CbGbCtD
Norethindrone—CYP3A4—Dasatinib—hematologic cancer	0.00235	0.00582	CbGbCtD
Norethindrone—CYP3A4—Mitoxantrone—hematologic cancer	0.00232	0.00574	CbGbCtD
Norethindrone—CYP3A4—Betamethasone—hematologic cancer	0.00207	0.00512	CbGbCtD
Norethindrone—CYP3A4—Prednisolone—hematologic cancer	0.00204	0.00505	CbGbCtD
Norethindrone—ABCB1—Dexamethasone—hematologic cancer	0.00201	0.00497	CbGbCtD
Norethindrone—CYP3A4—Prednisone—hematologic cancer	0.00193	0.00477	CbGbCtD
Norethindrone—CYP3A4—Irinotecan—hematologic cancer	0.00183	0.00452	CbGbCtD
Norethindrone—ABCB1—Doxorubicin—hematologic cancer	0.00167	0.00412	CbGbCtD
Norethindrone—CYP3A4—Vinblastine—hematologic cancer	0.00162	0.00402	CbGbCtD
Norethindrone—ABCB1—Methotrexate—hematologic cancer	0.00161	0.00399	CbGbCtD
Norethindrone—CYP3A4—Vincristine—hematologic cancer	0.0016	0.00395	CbGbCtD
Norethindrone—CYP3A4—Etoposide—hematologic cancer	0.00146	0.00362	CbGbCtD
Norethindrone—CYP3A4—Dexamethasone—hematologic cancer	0.0012	0.00298	CbGbCtD
Norethindrone—SHBG—hematopoietic system—hematologic cancer	0.00101	0.0528	CbGeAlD
Norethindrone—CYP3A4—Doxorubicin—hematologic cancer	0.000998	0.00247	CbGbCtD
Norethindrone—PGR—hematopoietic system—hematologic cancer	0.000913	0.0476	CbGeAlD
Norethindrone—SHBG—gonad—hematologic cancer	0.000771	0.0401	CbGeAlD
Norethindrone—CYP2C19—hematopoietic system—hematologic cancer	0.000674	0.0351	CbGeAlD
Norethindrone—SHBG—blood—hematologic cancer	0.000672	0.035	CbGeAlD
Norethindrone—SHBG—bone marrow—hematologic cancer	0.00065	0.0339	CbGeAlD
Norethindrone—PGR—blood—hematologic cancer	0.000605	0.0315	CbGeAlD
Norethindrone—SHBG—testis—hematologic cancer	0.000556	0.0289	CbGeAlD
Norethindrone—CYP3A5—hematopoietic system—hematologic cancer	0.000531	0.0277	CbGeAlD
Norethindrone—PGR—lung—hematologic cancer	0.00053	0.0276	CbGeAlD
Norethindrone—PGR—testis—hematologic cancer	0.000501	0.0261	CbGeAlD
Norethindrone—ALB—testis—hematologic cancer	0.000459	0.0239	CbGeAlD
Norethindrone—CYP2C19—blood—hematologic cancer	0.000447	0.0233	CbGeAlD
Norethindrone—CYP3A4—hematopoietic system—hematologic cancer	0.000399	0.0208	CbGeAlD
Norethindrone—PGR—lymph node—hematologic cancer	0.000363	0.0189	CbGeAlD
Norethindrone—CYP3A5—blood—hematologic cancer	0.000352	0.0183	CbGeAlD
Norethindrone—ALB—lymph node—hematologic cancer	0.000333	0.0173	CbGeAlD
Norethindrone—CYP3A5—lung—hematologic cancer	0.000308	0.0161	CbGeAlD
Norethindrone—ABCB1—hematopoietic system—hematologic cancer	0.000282	0.0147	CbGeAlD
Norethindrone—Stanozolol—AR—hematologic cancer	0.000274	0.0756	CrCbGaD
Norethindrone—CYP3A4—blood—hematologic cancer	0.000264	0.0138	CbGeAlD
Norethindrone—Oxandrolone—AR—hematologic cancer	0.000246	0.0681	CrCbGaD
Norethindrone—ABCB1—gonad—hematologic cancer	0.000215	0.0112	CbGeAlD
Norethindrone—Nandrolone phenpropionate—AR—hematologic cancer	0.000193	0.0533	CrCbGaD
Norethindrone—ABCB1—blood—hematologic cancer	0.000187	0.00974	CbGeAlD
Norethindrone—ABCB1—bone marrow—hematologic cancer	0.000181	0.00942	CbGeAlD
Norethindrone—Danazol—CCL2—hematologic cancer	0.000177	0.049	CrCbGaD
Norethindrone—Quinestrol—ESR1—hematologic cancer	0.000175	0.0483	CrCbGaD
Norethindrone—ABCB1—lung—hematologic cancer	0.000164	0.00853	CbGeAlD
Norethindrone—ABCB1—testis—hematologic cancer	0.000155	0.00805	CbGeAlD
Norethindrone—Nandrolone decanoate—AR—hematologic cancer	0.000146	0.0404	CrCbGaD
Norethindrone—Ethynodiol—ESR1—hematologic cancer	0.000144	0.0397	CrCbGaD
Norethindrone—Testosterone Propionate—UGT1A1—hematologic cancer	0.00014	0.0386	CrCbGaD
Norethindrone—Allylestrenol—ESR1—hematologic cancer	0.000136	0.0375	CrCbGaD
Norethindrone—Mestranol—ESR1—hematologic cancer	0.000132	0.0366	CrCbGaD
Norethindrone—Desogestrel—ESR1—hematologic cancer	0.000131	0.0361	CrCbGaD
Norethindrone—Norgestimate—ESR1—hematologic cancer	0.000122	0.0338	CrCbGaD
Norethindrone—Drospirenone—AR—hematologic cancer	0.000119	0.0329	CrCbGaD
Norethindrone—ABCB1—lymph node—hematologic cancer	0.000112	0.00584	CbGeAlD
Norethindrone—Etonogestrel—ESR1—hematologic cancer	0.000106	0.0292	CrCbGaD
Norethindrone—Testosterone Propionate—AR—hematologic cancer	0.0001	0.0276	CrCbGaD
Norethindrone—Levonorgestrel—AR—hematologic cancer	9.72e-05	0.0269	CrCbGaD
Norethindrone—Cortisone acetate—NR3C1—hematologic cancer	9.6e-05	0.0265	CrCbGaD
Norethindrone—Fluoxymesterone—AR—hematologic cancer	9.26e-05	0.0256	CrCbGaD
Norethindrone—Danazol—AR—hematologic cancer	8.85e-05	0.0245	CrCbGaD
Norethindrone—Levonorgestrel—ESR1—hematologic cancer	7.49e-05	0.0207	CrCbGaD
Norethindrone—Methyltestosterone—AR—hematologic cancer	7.48e-05	0.0207	CrCbGaD
Norethindrone—Fluoxymesterone—ESR1—hematologic cancer	7.14e-05	0.0197	CrCbGaD
Norethindrone—Danazol—ESR1—hematologic cancer	6.82e-05	0.0188	CrCbGaD
Norethindrone—Ethinyl Estradiol—ESR1—hematologic cancer	6.31e-05	0.0174	CrCbGaD
Norethindrone—Fluoxymesterone—NR3C1—hematologic cancer	6.28e-05	0.0174	CrCbGaD
Norethindrone—Progesterone—SLC22A1—hematologic cancer	5.17e-05	0.0143	CrCbGaD
Norethindrone—Testosterone—SLC22A1—hematologic cancer	4.88e-05	0.0135	CrCbGaD
Norethindrone—Progesterone—AR—hematologic cancer	4.59e-05	0.0127	CrCbGaD
Norethindrone—Hydrocortisone—ABCG2—hematologic cancer	4.43e-05	0.0122	CrCbGaD
Norethindrone—Testosterone—AR—hematologic cancer	4.34e-05	0.012	CrCbGaD
Norethindrone—Hydrocortisone—NR3C1—hematologic cancer	3.82e-05	0.0106	CrCbGaD
Norethindrone—Progesterone—ESR1—hematologic cancer	3.54e-05	0.00977	CrCbGaD
Norethindrone—Testosterone—ABCG2—hematologic cancer	3.41e-05	0.00943	CrCbGaD
Norethindrone—Progesterone—NR3C1—hematologic cancer	3.11e-05	0.0086	CrCbGaD
Norethindrone—Rash—Thiotepa—hematologic cancer	3.02e-05	0.000205	CcSEcCtD
Norethindrone—Dermatitis—Thiotepa—hematologic cancer	3.02e-05	0.000205	CcSEcCtD
Norethindrone—Convulsion—Betamethasone—hematologic cancer	3e-05	0.000204	CcSEcCtD
Norethindrone—Convulsion—Dexamethasone—hematologic cancer	3e-05	0.000204	CcSEcCtD
Norethindrone—Headache—Thiotepa—hematologic cancer	3e-05	0.000204	CcSEcCtD
Norethindrone—Nausea—Vinorelbine—hematologic cancer	2.98e-05	0.000202	CcSEcCtD
Norethindrone—Renal failure—Epirubicin—hematologic cancer	2.97e-05	0.000202	CcSEcCtD
Norethindrone—Gastrointestinal disorder—Etoposide—hematologic cancer	2.97e-05	0.000202	CcSEcCtD
Norethindrone—Asthenia—Irinotecan—hematologic cancer	2.97e-05	0.000202	CcSEcCtD
Norethindrone—Asthenia—Mitoxantrone—hematologic cancer	2.97e-05	0.000202	CcSEcCtD
Norethindrone—Fatigue—Etoposide—hematologic cancer	2.96e-05	0.000201	CcSEcCtD
Norethindrone—Vomiting—Thalidomide—hematologic cancer	2.94e-05	0.0002	CcSEcCtD
Norethindrone—Dizziness—Carmustine—hematologic cancer	2.94e-05	0.0002	CcSEcCtD
Norethindrone—Rash—Thalidomide—hematologic cancer	2.92e-05	0.000198	CcSEcCtD
Norethindrone—Dermatitis—Thalidomide—hematologic cancer	2.92e-05	0.000198	CcSEcCtD
Norethindrone—Haemoglobin—Methotrexate—hematologic cancer	2.91e-05	0.000198	CcSEcCtD
Norethindrone—Dizziness—Alitretinoin—hematologic cancer	2.91e-05	0.000198	CcSEcCtD
Norethindrone—Headache—Thalidomide—hematologic cancer	2.9e-05	0.000197	CcSEcCtD
Norethindrone—Haemorrhage—Methotrexate—hematologic cancer	2.9e-05	0.000197	CcSEcCtD
Norethindrone—Hepatitis—Methotrexate—hematologic cancer	2.9e-05	0.000197	CcSEcCtD
Norethindrone—Asthenia—Gemcitabine—hematologic cancer	2.89e-05	0.000196	CcSEcCtD
Norethindrone—Dizziness—Ifosfamide—hematologic cancer	2.88e-05	0.000196	CcSEcCtD
Norethindrone—Photosensitivity reaction—Doxorubicin—hematologic cancer	2.86e-05	0.000195	CcSEcCtD
Norethindrone—Hepatobiliary disease—Epirubicin—hematologic cancer	2.86e-05	0.000194	CcSEcCtD
Norethindrone—Weight increased—Doxorubicin—hematologic cancer	2.85e-05	0.000194	CcSEcCtD
Norethindrone—Pruritus—Gemcitabine—hematologic cancer	2.85e-05	0.000194	CcSEcCtD
Norethindrone—Nausea—Thiotepa—hematologic cancer	2.84e-05	0.000193	CcSEcCtD
Norethindrone—Anaphylactic shock—Dexamethasone—hematologic cancer	2.83e-05	0.000192	CcSEcCtD
Norethindrone—Oedema—Betamethasone—hematologic cancer	2.83e-05	0.000192	CcSEcCtD
Norethindrone—Anaphylactic shock—Betamethasone—hematologic cancer	2.83e-05	0.000192	CcSEcCtD
Norethindrone—Oedema—Dexamethasone—hematologic cancer	2.83e-05	0.000192	CcSEcCtD
Norethindrone—Vomiting—Carmustine—hematologic cancer	2.83e-05	0.000192	CcSEcCtD
Norethindrone—Insomnia—Triamcinolone—hematologic cancer	2.82e-05	0.000192	CcSEcCtD
Norethindrone—Gastrointestinal pain—Etoposide—hematologic cancer	2.81e-05	0.000191	CcSEcCtD
Norethindrone—Dizziness—Vincristine—hematologic cancer	2.81e-05	0.000191	CcSEcCtD
Norethindrone—Rash—Carmustine—hematologic cancer	2.8e-05	0.000191	CcSEcCtD
Norethindrone—Dermatitis—Carmustine—hematologic cancer	2.8e-05	0.00019	CcSEcCtD
Norethindrone—Vomiting—Alitretinoin—hematologic cancer	2.8e-05	0.00019	CcSEcCtD
Norethindrone—Drowsiness—Doxorubicin—hematologic cancer	2.8e-05	0.00019	CcSEcCtD
Norethindrone—Headache—Carmustine—hematologic cancer	2.79e-05	0.000189	CcSEcCtD
Norethindrone—Rash—Alitretinoin—hematologic cancer	2.78e-05	0.000189	CcSEcCtD
Norethindrone—Dermatitis—Alitretinoin—hematologic cancer	2.77e-05	0.000189	CcSEcCtD
Norethindrone—Vomiting—Ifosfamide—hematologic cancer	2.77e-05	0.000188	CcSEcCtD
Norethindrone—Hypersensitivity—Cisplatin—hematologic cancer	2.77e-05	0.000188	CcSEcCtD
Norethindrone—Headache—Alitretinoin—hematologic cancer	2.76e-05	0.000188	CcSEcCtD
Norethindrone—Nausea—Thalidomide—hematologic cancer	2.75e-05	0.000187	CcSEcCtD
Norethindrone—Renal failure—Doxorubicin—hematologic cancer	2.75e-05	0.000187	CcSEcCtD
Norethindrone—Dyspepsia—Triamcinolone—hematologic cancer	2.75e-05	0.000187	CcSEcCtD
Norethindrone—Rash—Ifosfamide—hematologic cancer	2.74e-05	0.000187	CcSEcCtD
Norethindrone—Dermatitis—Ifosfamide—hematologic cancer	2.74e-05	0.000186	CcSEcCtD
Norethindrone—Erythema multiforme—Methotrexate—hematologic cancer	2.74e-05	0.000186	CcSEcCtD
Norethindrone—Dizziness—Irinotecan—hematologic cancer	2.73e-05	0.000186	CcSEcCtD
Norethindrone—Urticaria—Etoposide—hematologic cancer	2.73e-05	0.000186	CcSEcCtD
Norethindrone—Haemoglobin—Epirubicin—hematologic cancer	2.73e-05	0.000185	CcSEcCtD
Norethindrone—Abdominal pain—Etoposide—hematologic cancer	2.72e-05	0.000185	CcSEcCtD
Norethindrone—Hepatitis—Epirubicin—hematologic cancer	2.71e-05	0.000184	CcSEcCtD
Norethindrone—Haemorrhage—Epirubicin—hematologic cancer	2.71e-05	0.000184	CcSEcCtD
Norethindrone—Vomiting—Vincristine—hematologic cancer	2.7e-05	0.000183	CcSEcCtD
Norethindrone—Urticaria—Prednisolone—hematologic cancer	2.69e-05	0.000183	CcSEcCtD
Norethindrone—Asthenia—Cisplatin—hematologic cancer	2.69e-05	0.000183	CcSEcCtD
Norethindrone—Fatigue—Triamcinolone—hematologic cancer	2.69e-05	0.000183	CcSEcCtD
Norethindrone—Ethinyl Estradiol—ABCB1—hematologic cancer	2.68e-05	0.00741	CrCbGaD
Norethindrone—Rash—Vincristine—hematologic cancer	2.68e-05	0.000182	CcSEcCtD
Norethindrone—Dermatitis—Vincristine—hematologic cancer	2.67e-05	0.000182	CcSEcCtD
Norethindrone—Connective tissue disorder—Epirubicin—hematologic cancer	2.67e-05	0.000181	CcSEcCtD
Norethindrone—Headache—Vincristine—hematologic cancer	2.66e-05	0.000181	CcSEcCtD
Norethindrone—Hepatobiliary disease—Doxorubicin—hematologic cancer	2.64e-05	0.00018	CcSEcCtD
Norethindrone—Nausea—Carmustine—hematologic cancer	2.64e-05	0.000179	CcSEcCtD
Norethindrone—Vomiting—Mitoxantrone—hematologic cancer	2.63e-05	0.000179	CcSEcCtD
Norethindrone—Vomiting—Irinotecan—hematologic cancer	2.63e-05	0.000179	CcSEcCtD
Norethindrone—Immune system disorder—Methotrexate—hematologic cancer	2.62e-05	0.000178	CcSEcCtD
Norethindrone—Nausea—Alitretinoin—hematologic cancer	2.62e-05	0.000178	CcSEcCtD
Norethindrone—Convulsion—Prednisone—hematologic cancer	2.62e-05	0.000178	CcSEcCtD
Norethindrone—Rash—Mitoxantrone—hematologic cancer	2.61e-05	0.000177	CcSEcCtD
Norethindrone—Rash—Irinotecan—hematologic cancer	2.61e-05	0.000177	CcSEcCtD
Norethindrone—Dermatitis—Mitoxantrone—hematologic cancer	2.6e-05	0.000177	CcSEcCtD
Norethindrone—Dermatitis—Irinotecan—hematologic cancer	2.6e-05	0.000177	CcSEcCtD
Norethindrone—Headache—Mitoxantrone—hematologic cancer	2.59e-05	0.000176	CcSEcCtD
Norethindrone—Headache—Irinotecan—hematologic cancer	2.59e-05	0.000176	CcSEcCtD
Norethindrone—Nausea—Ifosfamide—hematologic cancer	2.59e-05	0.000176	CcSEcCtD
Norethindrone—Methyltestosterone—ALB—hematologic cancer	2.57e-05	0.00709	CrCbGaD
Norethindrone—Erythema multiforme—Epirubicin—hematologic cancer	2.56e-05	0.000174	CcSEcCtD
Norethindrone—Alopecia—Methotrexate—hematologic cancer	2.56e-05	0.000174	CcSEcCtD
Norethindrone—Vomiting—Gemcitabine—hematologic cancer	2.56e-05	0.000174	CcSEcCtD
Norethindrone—Insomnia—Betamethasone—hematologic cancer	2.56e-05	0.000174	CcSEcCtD
Norethindrone—Insomnia—Dexamethasone—hematologic cancer	2.56e-05	0.000174	CcSEcCtD
Norethindrone—Unspecified disorder of skin and subcutaneous tissue—Prednisone—hematologic cancer	2.55e-05	0.000174	CcSEcCtD
Norethindrone—Mental disorder—Methotrexate—hematologic cancer	2.54e-05	0.000173	CcSEcCtD
Norethindrone—Rash—Gemcitabine—hematologic cancer	2.54e-05	0.000173	CcSEcCtD
Norethindrone—Dermatitis—Gemcitabine—hematologic cancer	2.54e-05	0.000172	CcSEcCtD
Norethindrone—Hypersensitivity—Etoposide—hematologic cancer	2.53e-05	0.000172	CcSEcCtD
Norethindrone—Haemoglobin—Doxorubicin—hematologic cancer	2.52e-05	0.000171	CcSEcCtD
Norethindrone—Headache—Gemcitabine—hematologic cancer	2.52e-05	0.000171	CcSEcCtD
Norethindrone—Nausea—Vincristine—hematologic cancer	2.52e-05	0.000171	CcSEcCtD
Norethindrone—Haemorrhage—Doxorubicin—hematologic cancer	2.51e-05	0.000171	CcSEcCtD
Norethindrone—Hepatitis—Doxorubicin—hematologic cancer	2.51e-05	0.000171	CcSEcCtD
Norethindrone—Hypersensitivity—Prednisolone—hematologic cancer	2.5e-05	0.00017	CcSEcCtD
Norethindrone—Dyspepsia—Dexamethasone—hematologic cancer	2.49e-05	0.000169	CcSEcCtD
Norethindrone—Dyspepsia—Betamethasone—hematologic cancer	2.49e-05	0.000169	CcSEcCtD
Norethindrone—Urticaria—Triamcinolone—hematologic cancer	2.48e-05	0.000168	CcSEcCtD
Norethindrone—Asthenia—Etoposide—hematologic cancer	2.47e-05	0.000168	CcSEcCtD
Norethindrone—Connective tissue disorder—Doxorubicin—hematologic cancer	2.47e-05	0.000168	CcSEcCtD
Norethindrone—Anaphylactic shock—Prednisone—hematologic cancer	2.46e-05	0.000167	CcSEcCtD
Norethindrone—Oedema—Prednisone—hematologic cancer	2.46e-05	0.000167	CcSEcCtD
Norethindrone—Nausea—Mitoxantrone—hematologic cancer	2.46e-05	0.000167	CcSEcCtD
Norethindrone—Nausea—Irinotecan—hematologic cancer	2.46e-05	0.000167	CcSEcCtD
Norethindrone—Immune system disorder—Epirubicin—hematologic cancer	2.45e-05	0.000167	CcSEcCtD
Norethindrone—Gastrointestinal disorder—Betamethasone—hematologic cancer	2.44e-05	0.000166	CcSEcCtD
Norethindrone—Gastrointestinal disorder—Dexamethasone—hematologic cancer	2.44e-05	0.000166	CcSEcCtD
Norethindrone—Fatigue—Betamethasone—hematologic cancer	2.44e-05	0.000166	CcSEcCtD
Norethindrone—Fatigue—Dexamethasone—hematologic cancer	2.44e-05	0.000166	CcSEcCtD
Norethindrone—Pruritus—Etoposide—hematologic cancer	2.43e-05	0.000165	CcSEcCtD
Norethindrone—Alopecia—Epirubicin—hematologic cancer	2.4e-05	0.000163	CcSEcCtD
Norethindrone—Skin disorder—Prednisone—hematologic cancer	2.39e-05	0.000163	CcSEcCtD
Norethindrone—Nausea—Gemcitabine—hematologic cancer	2.39e-05	0.000163	CcSEcCtD
Norethindrone—Vomiting—Cisplatin—hematologic cancer	2.39e-05	0.000162	CcSEcCtD
Norethindrone—Mental disorder—Epirubicin—hematologic cancer	2.38e-05	0.000162	CcSEcCtD
Norethindrone—Erythema multiforme—Doxorubicin—hematologic cancer	2.37e-05	0.000161	CcSEcCtD
Norethindrone—Rash—Cisplatin—hematologic cancer	2.37e-05	0.000161	CcSEcCtD
Norethindrone—Dermatitis—Cisplatin—hematologic cancer	2.36e-05	0.000161	CcSEcCtD
Norethindrone—Flatulence—Epirubicin—hematologic cancer	2.33e-05	0.000158	CcSEcCtD
Norethindrone—Tension—Epirubicin—hematologic cancer	2.32e-05	0.000157	CcSEcCtD
Norethindrone—Gastrointestinal pain—Dexamethasone—hematologic cancer	2.31e-05	0.000157	CcSEcCtD
Norethindrone—Gastrointestinal pain—Betamethasone—hematologic cancer	2.31e-05	0.000157	CcSEcCtD
Norethindrone—Hypersensitivity—Triamcinolone—hematologic cancer	2.3e-05	0.000156	CcSEcCtD
Norethindrone—Nervousness—Epirubicin—hematologic cancer	2.29e-05	0.000156	CcSEcCtD
Norethindrone—Dizziness—Etoposide—hematologic cancer	2.27e-05	0.000155	CcSEcCtD
Norethindrone—Immune system disorder—Doxorubicin—hematologic cancer	2.27e-05	0.000154	CcSEcCtD
Norethindrone—Urticaria—Betamethasone—hematologic cancer	2.25e-05	0.000153	CcSEcCtD
Norethindrone—Urticaria—Dexamethasone—hematologic cancer	2.25e-05	0.000153	CcSEcCtD
Norethindrone—Dizziness—Prednisolone—hematologic cancer	2.24e-05	0.000152	CcSEcCtD
Norethindrone—Asthenia—Triamcinolone—hematologic cancer	2.24e-05	0.000152	CcSEcCtD
Norethindrone—Abdominal pain—Betamethasone—hematologic cancer	2.24e-05	0.000152	CcSEcCtD
Norethindrone—Abdominal pain—Dexamethasone—hematologic cancer	2.24e-05	0.000152	CcSEcCtD
Norethindrone—Nausea—Cisplatin—hematologic cancer	2.23e-05	0.000152	CcSEcCtD
Norethindrone—Insomnia—Prednisone—hematologic cancer	2.23e-05	0.000151	CcSEcCtD
Norethindrone—Alopecia—Doxorubicin—hematologic cancer	2.22e-05	0.000151	CcSEcCtD
Norethindrone—Pruritus—Triamcinolone—hematologic cancer	2.21e-05	0.00015	CcSEcCtD
Norethindrone—Mental disorder—Doxorubicin—hematologic cancer	2.2e-05	0.000149	CcSEcCtD
Norethindrone—Convulsion—Methotrexate—hematologic cancer	2.19e-05	0.000149	CcSEcCtD
Norethindrone—Vomiting—Etoposide—hematologic cancer	2.19e-05	0.000149	CcSEcCtD
Norethindrone—Dyspepsia—Prednisone—hematologic cancer	2.17e-05	0.000147	CcSEcCtD
Norethindrone—Rash—Etoposide—hematologic cancer	2.17e-05	0.000147	CcSEcCtD
Norethindrone—Dermatitis—Etoposide—hematologic cancer	2.17e-05	0.000147	CcSEcCtD
Norethindrone—Headache—Etoposide—hematologic cancer	2.15e-05	0.000146	CcSEcCtD
Norethindrone—Flatulence—Doxorubicin—hematologic cancer	2.15e-05	0.000146	CcSEcCtD
Norethindrone—Tension—Doxorubicin—hematologic cancer	2.14e-05	0.000146	CcSEcCtD
Norethindrone—Rash—Prednisolone—hematologic cancer	2.14e-05	0.000145	CcSEcCtD
Norethindrone—Dermatitis—Prednisolone—hematologic cancer	2.14e-05	0.000145	CcSEcCtD
Norethindrone—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—hematologic cancer	2.13e-05	0.000145	CcSEcCtD
Norethindrone—Fatigue—Prednisone—hematologic cancer	2.12e-05	0.000144	CcSEcCtD
Norethindrone—Headache—Prednisolone—hematologic cancer	2.12e-05	0.000144	CcSEcCtD
Norethindrone—Nervousness—Doxorubicin—hematologic cancer	2.12e-05	0.000144	CcSEcCtD
Norethindrone—Dizziness—Triamcinolone—hematologic cancer	2.06e-05	0.00014	CcSEcCtD
Norethindrone—Anaphylactic shock—Methotrexate—hematologic cancer	2.06e-05	0.00014	CcSEcCtD
Norethindrone—Convulsion—Epirubicin—hematologic cancer	2.05e-05	0.000139	CcSEcCtD
Norethindrone—Nausea—Etoposide—hematologic cancer	2.04e-05	0.000139	CcSEcCtD
Norethindrone—Asthenia—Dexamethasone—hematologic cancer	2.03e-05	0.000138	CcSEcCtD
Norethindrone—Asthenia—Betamethasone—hematologic cancer	2.03e-05	0.000138	CcSEcCtD
Norethindrone—Gastrointestinal pain—Prednisone—hematologic cancer	2.02e-05	0.000137	CcSEcCtD
Norethindrone—Nausea—Prednisolone—hematologic cancer	2.01e-05	0.000137	CcSEcCtD
Norethindrone—Pruritus—Dexamethasone—hematologic cancer	2e-05	0.000136	CcSEcCtD
Norethindrone—Pruritus—Betamethasone—hematologic cancer	2e-05	0.000136	CcSEcCtD
Norethindrone—Skin disorder—Methotrexate—hematologic cancer	2e-05	0.000136	CcSEcCtD
Norethindrone—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—hematologic cancer	2e-05	0.000136	CcSEcCtD
Norethindrone—Vomiting—Triamcinolone—hematologic cancer	1.98e-05	0.000135	CcSEcCtD
Norethindrone—Rash—Triamcinolone—hematologic cancer	1.97e-05	0.000134	CcSEcCtD
Norethindrone—Dermatitis—Triamcinolone—hematologic cancer	1.96e-05	0.000134	CcSEcCtD
Norethindrone—Urticaria—Prednisone—hematologic cancer	1.96e-05	0.000133	CcSEcCtD
Norethindrone—Headache—Triamcinolone—hematologic cancer	1.95e-05	0.000133	CcSEcCtD
Norethindrone—Abdominal pain—Prednisone—hematologic cancer	1.95e-05	0.000132	CcSEcCtD
Norethindrone—Oedema—Epirubicin—hematologic cancer	1.93e-05	0.000131	CcSEcCtD
Norethindrone—Anaphylactic shock—Epirubicin—hematologic cancer	1.93e-05	0.000131	CcSEcCtD
Norethindrone—Convulsion—Doxorubicin—hematologic cancer	1.89e-05	0.000129	CcSEcCtD
Norethindrone—Skin disorder—Epirubicin—hematologic cancer	1.87e-05	0.000127	CcSEcCtD
Norethindrone—Dizziness—Dexamethasone—hematologic cancer	1.87e-05	0.000127	CcSEcCtD
Norethindrone—Dizziness—Betamethasone—hematologic cancer	1.87e-05	0.000127	CcSEcCtD
Norethindrone—Insomnia—Methotrexate—hematologic cancer	1.86e-05	0.000127	CcSEcCtD
Norethindrone—Nausea—Triamcinolone—hematologic cancer	1.85e-05	0.000126	CcSEcCtD
Norethindrone—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—hematologic cancer	1.85e-05	0.000126	CcSEcCtD
Norethindrone—Hydrocortisone—ABCB1—hematologic cancer	1.84e-05	0.00509	CrCbGaD
Norethindrone—Somnolence—Methotrexate—hematologic cancer	1.83e-05	0.000124	CcSEcCtD
Norethindrone—Hypersensitivity—Prednisone—hematologic cancer	1.82e-05	0.000123	CcSEcCtD
Norethindrone—Dyspepsia—Methotrexate—hematologic cancer	1.81e-05	0.000123	CcSEcCtD
Norethindrone—Vomiting—Dexamethasone—hematologic cancer	1.8e-05	0.000122	CcSEcCtD
Norethindrone—Vomiting—Betamethasone—hematologic cancer	1.8e-05	0.000122	CcSEcCtD
Norethindrone—Rash—Dexamethasone—hematologic cancer	1.78e-05	0.000121	CcSEcCtD
Norethindrone—Rash—Betamethasone—hematologic cancer	1.78e-05	0.000121	CcSEcCtD
Norethindrone—Anaphylactic shock—Doxorubicin—hematologic cancer	1.78e-05	0.000121	CcSEcCtD
Norethindrone—Oedema—Doxorubicin—hematologic cancer	1.78e-05	0.000121	CcSEcCtD
Norethindrone—Dermatitis—Dexamethasone—hematologic cancer	1.78e-05	0.000121	CcSEcCtD
Norethindrone—Dermatitis—Betamethasone—hematologic cancer	1.78e-05	0.000121	CcSEcCtD
Norethindrone—Gastrointestinal disorder—Methotrexate—hematologic cancer	1.78e-05	0.000121	CcSEcCtD
Norethindrone—Fatigue—Methotrexate—hematologic cancer	1.78e-05	0.000121	CcSEcCtD
Norethindrone—Headache—Betamethasone—hematologic cancer	1.77e-05	0.00012	CcSEcCtD
Norethindrone—Headache—Dexamethasone—hematologic cancer	1.77e-05	0.00012	CcSEcCtD
Norethindrone—Asthenia—Prednisone—hematologic cancer	1.77e-05	0.00012	CcSEcCtD
Norethindrone—Pruritus—Prednisone—hematologic cancer	1.74e-05	0.000118	CcSEcCtD
Norethindrone—Insomnia—Epirubicin—hematologic cancer	1.74e-05	0.000118	CcSEcCtD
Norethindrone—Skin disorder—Doxorubicin—hematologic cancer	1.73e-05	0.000118	CcSEcCtD
Norethindrone—Somnolence—Epirubicin—hematologic cancer	1.71e-05	0.000116	CcSEcCtD
Norethindrone—Dyspepsia—Epirubicin—hematologic cancer	1.7e-05	0.000115	CcSEcCtD
Norethindrone—Gastrointestinal pain—Methotrexate—hematologic cancer	1.68e-05	0.000114	CcSEcCtD
Norethindrone—Nausea—Dexamethasone—hematologic cancer	1.68e-05	0.000114	CcSEcCtD
Norethindrone—Nausea—Betamethasone—hematologic cancer	1.68e-05	0.000114	CcSEcCtD
Norethindrone—Gastrointestinal disorder—Epirubicin—hematologic cancer	1.66e-05	0.000113	CcSEcCtD
Norethindrone—Fatigue—Epirubicin—hematologic cancer	1.66e-05	0.000113	CcSEcCtD
Norethindrone—Urticaria—Methotrexate—hematologic cancer	1.64e-05	0.000111	CcSEcCtD
Norethindrone—Dizziness—Prednisone—hematologic cancer	1.63e-05	0.000111	CcSEcCtD
Norethindrone—Abdominal pain—Methotrexate—hematologic cancer	1.63e-05	0.000111	CcSEcCtD
Norethindrone—Insomnia—Doxorubicin—hematologic cancer	1.61e-05	0.00011	CcSEcCtD
Norethindrone—Somnolence—Doxorubicin—hematologic cancer	1.59e-05	0.000108	CcSEcCtD
Norethindrone—Gastrointestinal pain—Epirubicin—hematologic cancer	1.58e-05	0.000107	CcSEcCtD
Norethindrone—Dyspepsia—Doxorubicin—hematologic cancer	1.57e-05	0.000107	CcSEcCtD
Norethindrone—Vomiting—Prednisone—hematologic cancer	1.57e-05	0.000106	CcSEcCtD
Norethindrone—Rash—Prednisone—hematologic cancer	1.55e-05	0.000106	CcSEcCtD
Norethindrone—Dermatitis—Prednisone—hematologic cancer	1.55e-05	0.000106	CcSEcCtD
Norethindrone—Headache—Prednisone—hematologic cancer	1.54e-05	0.000105	CcSEcCtD
Norethindrone—Gastrointestinal disorder—Doxorubicin—hematologic cancer	1.54e-05	0.000105	CcSEcCtD
Norethindrone—Fatigue—Doxorubicin—hematologic cancer	1.54e-05	0.000104	CcSEcCtD
Norethindrone—Urticaria—Epirubicin—hematologic cancer	1.53e-05	0.000104	CcSEcCtD
Norethindrone—Abdominal pain—Epirubicin—hematologic cancer	1.52e-05	0.000104	CcSEcCtD
Norethindrone—Hypersensitivity—Methotrexate—hematologic cancer	1.52e-05	0.000103	CcSEcCtD
Norethindrone—Progesterone—ABCB1—hematologic cancer	1.5e-05	0.00415	CrCbGaD
Norethindrone—Testosterone—ALB—hematologic cancer	1.49e-05	0.00411	CrCbGaD
Norethindrone—Asthenia—Methotrexate—hematologic cancer	1.48e-05	0.0001	CcSEcCtD
Norethindrone—Nausea—Prednisone—hematologic cancer	1.46e-05	9.95e-05	CcSEcCtD
Norethindrone—Gastrointestinal pain—Doxorubicin—hematologic cancer	1.46e-05	9.91e-05	CcSEcCtD
Norethindrone—Pruritus—Methotrexate—hematologic cancer	1.46e-05	9.9e-05	CcSEcCtD
Norethindrone—Testosterone—ABCB1—hematologic cancer	1.42e-05	0.00392	CrCbGaD
Norethindrone—Hypersensitivity—Epirubicin—hematologic cancer	1.42e-05	9.65e-05	CcSEcCtD
Norethindrone—Urticaria—Doxorubicin—hematologic cancer	1.42e-05	9.63e-05	CcSEcCtD
Norethindrone—Abdominal pain—Doxorubicin—hematologic cancer	1.41e-05	9.58e-05	CcSEcCtD
Norethindrone—Asthenia—Epirubicin—hematologic cancer	1.38e-05	9.4e-05	CcSEcCtD
Norethindrone—Pruritus—Epirubicin—hematologic cancer	1.36e-05	9.27e-05	CcSEcCtD
Norethindrone—Dizziness—Methotrexate—hematologic cancer	1.36e-05	9.26e-05	CcSEcCtD
Norethindrone—Hypersensitivity—Doxorubicin—hematologic cancer	1.31e-05	8.93e-05	CcSEcCtD
Norethindrone—Vomiting—Methotrexate—hematologic cancer	1.31e-05	8.9e-05	CcSEcCtD
Norethindrone—Rash—Methotrexate—hematologic cancer	1.3e-05	8.83e-05	CcSEcCtD
Norethindrone—Dermatitis—Methotrexate—hematologic cancer	1.3e-05	8.82e-05	CcSEcCtD
Norethindrone—Headache—Methotrexate—hematologic cancer	1.29e-05	8.77e-05	CcSEcCtD
Norethindrone—Asthenia—Doxorubicin—hematologic cancer	1.28e-05	8.7e-05	CcSEcCtD
Norethindrone—Dizziness—Epirubicin—hematologic cancer	1.27e-05	8.66e-05	CcSEcCtD
Norethindrone—Pruritus—Doxorubicin—hematologic cancer	1.26e-05	8.57e-05	CcSEcCtD
Norethindrone—Vomiting—Epirubicin—hematologic cancer	1.23e-05	8.33e-05	CcSEcCtD
Norethindrone—Nausea—Methotrexate—hematologic cancer	1.22e-05	8.31e-05	CcSEcCtD
Norethindrone—Rash—Epirubicin—hematologic cancer	1.22e-05	8.26e-05	CcSEcCtD
Norethindrone—Dermatitis—Epirubicin—hematologic cancer	1.21e-05	8.25e-05	CcSEcCtD
Norethindrone—Headache—Epirubicin—hematologic cancer	1.21e-05	8.21e-05	CcSEcCtD
Norethindrone—Dizziness—Doxorubicin—hematologic cancer	1.18e-05	8.01e-05	CcSEcCtD
Norethindrone—Nausea—Epirubicin—hematologic cancer	1.14e-05	7.78e-05	CcSEcCtD
Norethindrone—Vomiting—Doxorubicin—hematologic cancer	1.13e-05	7.71e-05	CcSEcCtD
Norethindrone—Rash—Doxorubicin—hematologic cancer	1.12e-05	7.64e-05	CcSEcCtD
Norethindrone—Dermatitis—Doxorubicin—hematologic cancer	1.12e-05	7.63e-05	CcSEcCtD
Norethindrone—Headache—Doxorubicin—hematologic cancer	1.12e-05	7.59e-05	CcSEcCtD
Norethindrone—Nausea—Doxorubicin—hematologic cancer	1.06e-05	7.2e-05	CcSEcCtD
Norethindrone—CYP2C19—Metabolism—UGT1A1—hematologic cancer	4.69e-06	0.000138	CbGpPWpGaD
Norethindrone—ALB—Hemostasis—CREBBP—hematologic cancer	4.66e-06	0.000137	CbGpPWpGaD
Norethindrone—ALB—Metabolism—ADCY7—hematologic cancer	4.65e-06	0.000137	CbGpPWpGaD
Norethindrone—ALB—Metabolism—NCOA3—hematologic cancer	4.65e-06	0.000137	CbGpPWpGaD
Norethindrone—CYP3A4—Metabolism—SLC35B2—hematologic cancer	4.65e-06	0.000137	CbGpPWpGaD
Norethindrone—CYP3A4—Metabolism—GBA—hematologic cancer	4.65e-06	0.000137	CbGpPWpGaD
Norethindrone—ALB—Metabolism—NUP214—hematologic cancer	4.62e-06	0.000136	CbGpPWpGaD
Norethindrone—ABCB1—Metabolism—UGT1A1—hematologic cancer	4.57e-06	0.000135	CbGpPWpGaD
Norethindrone—PGR—Signaling Pathways—CREB1—hematologic cancer	4.57e-06	0.000135	CbGpPWpGaD
Norethindrone—ALB—Metabolism of lipids and lipoproteins—PIK3CG—hematologic cancer	4.57e-06	0.000135	CbGpPWpGaD
Norethindrone—CYP2C19—Metabolism—SLC22A1—hematologic cancer	4.56e-06	0.000134	CbGpPWpGaD
Norethindrone—CYP2C19—Metabolism—CRABP1—hematologic cancer	4.56e-06	0.000134	CbGpPWpGaD
Norethindrone—ALB—Platelet activation, signaling and aggregation—PIK3CA—hematologic cancer	4.55e-06	0.000134	CbGpPWpGaD
Norethindrone—CYP3A7—Metabolism—ABCB1—hematologic cancer	4.54e-06	0.000134	CbGpPWpGaD
Norethindrone—ALB—Metabolism—ABCG2—hematologic cancer	4.53e-06	0.000133	CbGpPWpGaD
Norethindrone—ALB—Metabolism—MTR—hematologic cancer	4.53e-06	0.000133	CbGpPWpGaD
Norethindrone—PGR—Signaling Pathways—BRAF—hematologic cancer	4.51e-06	0.000133	CbGpPWpGaD
Norethindrone—ABCB1—Integrated Pancreatic Cancer Pathway—PIK3CA—hematologic cancer	4.48e-06	0.000132	CbGpPWpGaD
Norethindrone—PGR—Signaling Pathways—CCL2—hematologic cancer	4.47e-06	0.000132	CbGpPWpGaD
Norethindrone—PGR—Signaling Pathways—IL6R—hematologic cancer	4.46e-06	0.000131	CbGpPWpGaD
Norethindrone—PGR—Signaling Pathways—CREBBP—hematologic cancer	4.45e-06	0.000131	CbGpPWpGaD
Norethindrone—ABCB1—Metabolism—SLC22A1—hematologic cancer	4.45e-06	0.000131	CbGpPWpGaD
Norethindrone—ABCB1—Metabolism—CRABP1—hematologic cancer	4.45e-06	0.000131	CbGpPWpGaD
Norethindrone—CYP2C19—Metabolism—ALOX5—hematologic cancer	4.44e-06	0.000131	CbGpPWpGaD
Norethindrone—ALB—Metabolism—ENO2—hematologic cancer	4.44e-06	0.000131	CbGpPWpGaD
Norethindrone—ALB—Hemostasis—PIK3CD—hematologic cancer	4.41e-06	0.00013	CbGpPWpGaD
Norethindrone—CYP3A7—Metabolism—GSTM1—hematologic cancer	4.4e-06	0.00013	CbGpPWpGaD
Norethindrone—CYP3A7—Metabolism—NCOR1—hematologic cancer	4.4e-06	0.00013	CbGpPWpGaD
Norethindrone—ABCB1—Metabolism—ALOX5—hematologic cancer	4.34e-06	0.000128	CbGpPWpGaD
Norethindrone—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—hematologic cancer	4.33e-06	0.000128	CbGpPWpGaD
Norethindrone—ALB—Metabolism—GSTT1—hematologic cancer	4.3e-06	0.000127	CbGpPWpGaD
Norethindrone—CYP2C19—Metabolism—NUP98—hematologic cancer	4.3e-06	0.000127	CbGpPWpGaD
Norethindrone—CYP3A4—Metabolism—MTAP—hematologic cancer	4.25e-06	0.000125	CbGpPWpGaD
Norethindrone—PGR—Signaling Pathways—MAP2K1—hematologic cancer	4.25e-06	0.000125	CbGpPWpGaD
Norethindrone—ALB—Metabolism of lipids and lipoproteins—CREBBP—hematologic cancer	4.24e-06	0.000125	CbGpPWpGaD
Norethindrone—PGR—Signaling Pathways—PIK3CD—hematologic cancer	4.22e-06	0.000124	CbGpPWpGaD
Norethindrone—ALB—Metabolism—SDC1—hematologic cancer	4.21e-06	0.000124	CbGpPWpGaD
Norethindrone—ABCB1—Metabolism—NUP98—hematologic cancer	4.2e-06	0.000124	CbGpPWpGaD
Norethindrone—PGR—Gene Expression—MAPK3—hematologic cancer	4.18e-06	0.000123	CbGpPWpGaD
Norethindrone—CYP2C19—Metabolism—ADCY7—hematologic cancer	4.18e-06	0.000123	CbGpPWpGaD
Norethindrone—CYP2C19—Metabolism—NCOA3—hematologic cancer	4.18e-06	0.000123	CbGpPWpGaD
Norethindrone—ALB—Hemostasis—PIK3R1—hematologic cancer	4.17e-06	0.000123	CbGpPWpGaD
Norethindrone—CYP3A5—Metabolism—CD44—hematologic cancer	4.15e-06	0.000122	CbGpPWpGaD
Norethindrone—CYP3A5—Metabolism—NQO1—hematologic cancer	4.15e-06	0.000122	CbGpPWpGaD
Norethindrone—CYP2C19—Metabolism—NUP214—hematologic cancer	4.15e-06	0.000122	CbGpPWpGaD
Norethindrone—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CG—hematologic cancer	4.1e-06	0.000121	CbGpPWpGaD
Norethindrone—ABCB1—Metabolism—ADCY7—hematologic cancer	4.08e-06	0.00012	CbGpPWpGaD
Norethindrone—ABCB1—Metabolism—NCOA3—hematologic cancer	4.08e-06	0.00012	CbGpPWpGaD
Norethindrone—PGR—Gene Expression—MYC—hematologic cancer	4.06e-06	0.00012	CbGpPWpGaD
Norethindrone—CYP2C19—Metabolism—MTR—hematologic cancer	4.06e-06	0.00012	CbGpPWpGaD
Norethindrone—CYP2C19—Metabolism—ABCG2—hematologic cancer	4.06e-06	0.00012	CbGpPWpGaD
Norethindrone—ALB—Hemostasis—JAK2—hematologic cancer	4.05e-06	0.000119	CbGpPWpGaD
Norethindrone—ABCB1—Metabolism—NUP214—hematologic cancer	4.05e-06	0.000119	CbGpPWpGaD
Norethindrone—PGR—Signaling Pathways—FGF2—hematologic cancer	4.04e-06	0.000119	CbGpPWpGaD
Norethindrone—ALB—Transmembrane transport of small molecules—CREBBP—hematologic cancer	4.03e-06	0.000119	CbGpPWpGaD
Norethindrone—ALB—Metabolism of lipids and lipoproteins—PIK3CD—hematologic cancer	4.02e-06	0.000118	CbGpPWpGaD
Norethindrone—PGR—Signaling Pathways—PIK3R1—hematologic cancer	3.99e-06	0.000117	CbGpPWpGaD
Norethindrone—CYP2C19—Metabolism—ENO2—hematologic cancer	3.98e-06	0.000117	CbGpPWpGaD
Norethindrone—ABCB1—Metabolism—ABCG2—hematologic cancer	3.97e-06	0.000117	CbGpPWpGaD
Norethindrone—ABCB1—Metabolism—MTR—hematologic cancer	3.97e-06	0.000117	CbGpPWpGaD
Norethindrone—CYP3A5—Metabolism—CYCS—hematologic cancer	3.93e-06	0.000116	CbGpPWpGaD
Norethindrone—CYP3A5—Metabolism—HSP90AA1—hematologic cancer	3.91e-06	0.000115	CbGpPWpGaD
Norethindrone—CYP3A7—Metabolism—MTHFR—hematologic cancer	3.89e-06	0.000115	CbGpPWpGaD
Norethindrone—ABCB1—Metabolism—ENO2—hematologic cancer	3.89e-06	0.000115	CbGpPWpGaD
Norethindrone—PGR—Signaling Pathways—JAK2—hematologic cancer	3.88e-06	0.000114	CbGpPWpGaD
Norethindrone—CYP2C19—Metabolism—GSTT1—hematologic cancer	3.86e-06	0.000114	CbGpPWpGaD
Norethindrone—ALB—Hemostasis—PIK3CB—hematologic cancer	3.85e-06	0.000113	CbGpPWpGaD
Norethindrone—CYP2C19—Metabolism of lipids and lipoproteins—CREBBP—hematologic cancer	3.8e-06	0.000112	CbGpPWpGaD
Norethindrone—ALB—Metabolism of lipids and lipoproteins—PIK3R1—hematologic cancer	3.79e-06	0.000112	CbGpPWpGaD
Norethindrone—CYP3A4—Metabolism—FHL2—hematologic cancer	3.79e-06	0.000112	CbGpPWpGaD
Norethindrone—PGR—Signaling Pathways—MDM2—hematologic cancer	3.78e-06	0.000111	CbGpPWpGaD
Norethindrone—CYP2C19—Metabolism—SDC1—hematologic cancer	3.78e-06	0.000111	CbGpPWpGaD
Norethindrone—ABCB1—Metabolism—GSTT1—hematologic cancer	3.77e-06	0.000111	CbGpPWpGaD
Norethindrone—CYP3A4—Metabolism—AGRN—hematologic cancer	3.72e-06	0.00011	CbGpPWpGaD
Norethindrone—ALB—Platelet activation, signaling and aggregation—AKT1—hematologic cancer	3.72e-06	0.00011	CbGpPWpGaD
Norethindrone—ABCB1—Metabolism—SDC1—hematologic cancer	3.69e-06	0.000109	CbGpPWpGaD
Norethindrone—PGR—Signaling Pathways—MTOR—hematologic cancer	3.68e-06	0.000108	CbGpPWpGaD
Norethindrone—PGR—Signaling Pathways—PIK3CB—hematologic cancer	3.68e-06	0.000108	CbGpPWpGaD
Norethindrone—ABCB1—Integrated Pancreatic Cancer Pathway—AKT1—hematologic cancer	3.66e-06	0.000108	CbGpPWpGaD
Norethindrone—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CD—hematologic cancer	3.61e-06	0.000106	CbGpPWpGaD
Norethindrone—ALB—Metabolism—NQO1—hematologic cancer	3.58e-06	0.000105	CbGpPWpGaD
Norethindrone—ALB—Metabolism—CD44—hematologic cancer	3.58e-06	0.000105	CbGpPWpGaD
Norethindrone—CYP2C19—Metabolism of lipids and lipoproteins—ALB—hematologic cancer	3.56e-06	0.000105	CbGpPWpGaD
Norethindrone—ALB—Hemostasis—IL2—hematologic cancer	3.53e-06	0.000104	CbGpPWpGaD
Norethindrone—ABCB1—Transmembrane transport of small molecules—CREBBP—hematologic cancer	3.53e-06	0.000104	CbGpPWpGaD
Norethindrone—CYP3A4—Metabolism—HMMR—hematologic cancer	3.52e-06	0.000104	CbGpPWpGaD
Norethindrone—CYP3A4—Metabolism—IDH2—hematologic cancer	3.52e-06	0.000104	CbGpPWpGaD
Norethindrone—ALB—Metabolism of lipids and lipoproteins—PIK3CB—hematologic cancer	3.5e-06	0.000103	CbGpPWpGaD
Norethindrone—CYP3A5—Metabolism—GSTP1—hematologic cancer	3.46e-06	0.000102	CbGpPWpGaD
Norethindrone—PGR—Signaling Pathways—CDKN1B—hematologic cancer	3.45e-06	0.000102	CbGpPWpGaD
Norethindrone—CYP2C19—Metabolism of lipids and lipoproteins—PIK3R1—hematologic cancer	3.41e-06	0.0001	CbGpPWpGaD
Norethindrone—PGR—Signaling Pathways—CASP3—hematologic cancer	3.39e-06	9.97e-05	CbGpPWpGaD
Norethindrone—ALB—Metabolism—CYCS—hematologic cancer	3.38e-06	9.97e-05	CbGpPWpGaD
Norethindrone—PGR—Signaling Pathways—IL2—hematologic cancer	3.38e-06	9.96e-05	CbGpPWpGaD
Norethindrone—ALB—Metabolism—HSP90AA1—hematologic cancer	3.36e-06	9.91e-05	CbGpPWpGaD
Norethindrone—CYP3A4—Metabolism—ARNTL—hematologic cancer	3.31e-06	9.76e-05	CbGpPWpGaD
Norethindrone—ABCB1—Transmembrane transport of small molecules—ALB—hematologic cancer	3.31e-06	9.74e-05	CbGpPWpGaD
Norethindrone—PGR—Signaling Pathways—CCND1—hematologic cancer	3.3e-06	9.71e-05	CbGpPWpGaD
Norethindrone—PGR—Signaling Pathways—JUN—hematologic cancer	3.29e-06	9.69e-05	CbGpPWpGaD
Norethindrone—CYP3A5—Metabolism—ABCB1—hematologic cancer	3.28e-06	9.66e-05	CbGpPWpGaD
Norethindrone—CYP3A7—Metabolism—PIK3CG—hematologic cancer	3.27e-06	9.63e-05	CbGpPWpGaD
Norethindrone—CYP3A4—Metabolism—CA9—hematologic cancer	3.22e-06	9.5e-05	CbGpPWpGaD
Norethindrone—CYP3A4—Metabolism—ACP5—hematologic cancer	3.22e-06	9.5e-05	CbGpPWpGaD
Norethindrone—CYP2C19—Metabolism—CD44—hematologic cancer	3.21e-06	9.46e-05	CbGpPWpGaD
Norethindrone—CYP2C19—Metabolism—NQO1—hematologic cancer	3.21e-06	9.46e-05	CbGpPWpGaD
Norethindrone—PGR—Signaling Pathways—CDKN1A—hematologic cancer	3.19e-06	9.39e-05	CbGpPWpGaD
Norethindrone—CYP3A5—Metabolism—GSTM1—hematologic cancer	3.18e-06	9.38e-05	CbGpPWpGaD
Norethindrone—CYP3A5—Metabolism—NCOR1—hematologic cancer	3.18e-06	9.38e-05	CbGpPWpGaD
Norethindrone—CYP3A4—Metabolism—NCOR2—hematologic cancer	3.18e-06	9.37e-05	CbGpPWpGaD
Norethindrone—PGR—Signaling Pathways—PTEN—hematologic cancer	3.18e-06	9.37e-05	CbGpPWpGaD
Norethindrone—ALB—Hemostasis—EP300—hematologic cancer	3.17e-06	9.34e-05	CbGpPWpGaD
Norethindrone—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CB—hematologic cancer	3.14e-06	9.26e-05	CbGpPWpGaD
Norethindrone—ABCB1—Metabolism—NQO1—hematologic cancer	3.13e-06	9.23e-05	CbGpPWpGaD
Norethindrone—ABCB1—Metabolism—CD44—hematologic cancer	3.13e-06	9.23e-05	CbGpPWpGaD
Norethindrone—PGR—Signaling Pathways—MAPK8—hematologic cancer	3.11e-06	9.17e-05	CbGpPWpGaD
Norethindrone—ALB—Hemostasis—SRC—hematologic cancer	3.08e-06	9.08e-05	CbGpPWpGaD
Norethindrone—CYP2C19—Metabolism—CYCS—hematologic cancer	3.04e-06	8.95e-05	CbGpPWpGaD
Norethindrone—PGR—Signaling Pathways—EP300—hematologic cancer	3.03e-06	8.93e-05	CbGpPWpGaD
Norethindrone—CYP3A7—Metabolism—CREBBP—hematologic cancer	3.03e-06	8.93e-05	CbGpPWpGaD
Norethindrone—CYP3A4—Metabolism—IDH1—hematologic cancer	3.03e-06	8.93e-05	CbGpPWpGaD
Norethindrone—ALB—Metabolism of lipids and lipoproteins—PTEN—hematologic cancer	3.03e-06	8.92e-05	CbGpPWpGaD
Norethindrone—CYP2C19—Metabolism—HSP90AA1—hematologic cancer	3.02e-06	8.89e-05	CbGpPWpGaD
Norethindrone—ALB—Hemostasis—VEGFA—hematologic cancer	3e-06	8.85e-05	CbGpPWpGaD
Norethindrone—CYP3A4—Metabolism—TXN—hematologic cancer	3e-06	8.83e-05	CbGpPWpGaD
Norethindrone—CYP3A4—Metabolism—GSTO1—hematologic cancer	3e-06	8.83e-05	CbGpPWpGaD
Norethindrone—CYP3A4—Metabolism—ABCC3—hematologic cancer	3e-06	8.83e-05	CbGpPWpGaD
Norethindrone—ALB—Metabolism—GSTP1—hematologic cancer	2.98e-06	8.79e-05	CbGpPWpGaD
Norethindrone—ALB—Hemostasis—NRAS—hematologic cancer	2.97e-06	8.74e-05	CbGpPWpGaD
Norethindrone—ABCB1—Metabolism—CYCS—hematologic cancer	2.97e-06	8.74e-05	CbGpPWpGaD
Norethindrone—PGR—Signaling Pathways—SRC—hematologic cancer	2.95e-06	8.69e-05	CbGpPWpGaD
Norethindrone—ABCB1—Metabolism—HSP90AA1—hematologic cancer	2.95e-06	8.68e-05	CbGpPWpGaD
Norethindrone—CYP3A4—Metabolism—SPHK1—hematologic cancer	2.93e-06	8.64e-05	CbGpPWpGaD
Norethindrone—ALB—Metabolism of lipids and lipoproteins—EP300—hematologic cancer	2.89e-06	8.5e-05	CbGpPWpGaD
Norethindrone—CYP3A7—Metabolism—PIK3CD—hematologic cancer	2.87e-06	8.47e-05	CbGpPWpGaD
Norethindrone—PGR—Signaling Pathways—VEGFA—hematologic cancer	2.87e-06	8.46e-05	CbGpPWpGaD
Norethindrone—PGR—Signaling Pathways—STAT3—hematologic cancer	2.84e-06	8.38e-05	CbGpPWpGaD
Norethindrone—ALB—Hemostasis—MAPK3—hematologic cancer	2.84e-06	8.37e-05	CbGpPWpGaD
Norethindrone—CYP3A7—Metabolism—ALB—hematologic cancer	2.84e-06	8.36e-05	CbGpPWpGaD
Norethindrone—PGR—Signaling Pathways—NRAS—hematologic cancer	2.84e-06	8.36e-05	CbGpPWpGaD
Norethindrone—ALB—Metabolism—ABCB1—hematologic cancer	2.82e-06	8.32e-05	CbGpPWpGaD
Norethindrone—PGR—Gene Expression—AKT1—hematologic cancer	2.82e-06	8.3e-05	CbGpPWpGaD
Norethindrone—CYP3A4—Metabolism—UGT1A1—hematologic cancer	2.82e-06	8.3e-05	CbGpPWpGaD
Norethindrone—CYP3A5—Metabolism—MTHFR—hematologic cancer	2.81e-06	8.29e-05	CbGpPWpGaD
Norethindrone—ALB—Hemostasis—TGFB1—hematologic cancer	2.76e-06	8.12e-05	CbGpPWpGaD
Norethindrone—ALB—Metabolism—GSTM1—hematologic cancer	2.74e-06	8.08e-05	CbGpPWpGaD
Norethindrone—ALB—Metabolism—NCOR1—hematologic cancer	2.74e-06	8.08e-05	CbGpPWpGaD
Norethindrone—CYP3A4—Metabolism—SLC22A1—hematologic cancer	2.74e-06	8.07e-05	CbGpPWpGaD
Norethindrone—CYP3A4—Metabolism—CRABP1—hematologic cancer	2.74e-06	8.07e-05	CbGpPWpGaD
Norethindrone—PGR—Signaling Pathways—MAPK3—hematologic cancer	2.72e-06	8.01e-05	CbGpPWpGaD
Norethindrone—CYP2C19—Metabolism of lipids and lipoproteins—PTEN—hematologic cancer	2.72e-06	8e-05	CbGpPWpGaD
Norethindrone—CYP3A7—Metabolism—PIK3R1—hematologic cancer	2.71e-06	8e-05	CbGpPWpGaD
Norethindrone—CYP2C19—Metabolism—GSTP1—hematologic cancer	2.68e-06	7.89e-05	CbGpPWpGaD
Norethindrone—CYP3A4—Metabolism—ALOX5—hematologic cancer	2.67e-06	7.87e-05	CbGpPWpGaD
Norethindrone—PGR—Signaling Pathways—MYC—hematologic cancer	2.64e-06	7.79e-05	CbGpPWpGaD
Norethindrone—PGR—Signaling Pathways—TGFB1—hematologic cancer	2.64e-06	7.77e-05	CbGpPWpGaD
Norethindrone—ABCB1—Metabolism—GSTP1—hematologic cancer	2.61e-06	7.7e-05	CbGpPWpGaD
Norethindrone—CYP2C19—Metabolism of lipids and lipoproteins—EP300—hematologic cancer	2.59e-06	7.63e-05	CbGpPWpGaD
Norethindrone—CYP3A4—Metabolism—NUP98—hematologic cancer	2.59e-06	7.62e-05	CbGpPWpGaD
Norethindrone—ALB—Hemostasis—KRAS—hematologic cancer	2.55e-06	7.52e-05	CbGpPWpGaD
Norethindrone—CYP2C19—Metabolism—ABCB1—hematologic cancer	2.54e-06	7.47e-05	CbGpPWpGaD
Norethindrone—CYP3A4—Metabolism—ADCY7—hematologic cancer	2.51e-06	7.4e-05	CbGpPWpGaD
Norethindrone—CYP3A4—Metabolism—NCOA3—hematologic cancer	2.51e-06	7.4e-05	CbGpPWpGaD
Norethindrone—CYP3A7—Metabolism—PIK3CB—hematologic cancer	2.51e-06	7.38e-05	CbGpPWpGaD
Norethindrone—CYP3A4—Metabolism—NUP214—hematologic cancer	2.49e-06	7.35e-05	CbGpPWpGaD
Norethindrone—CYP2C19—Metabolism—NCOR1—hematologic cancer	2.46e-06	7.25e-05	CbGpPWpGaD
Norethindrone—CYP2C19—Metabolism—GSTM1—hematologic cancer	2.46e-06	7.25e-05	CbGpPWpGaD
Norethindrone—CYP3A4—Metabolism—ABCG2—hematologic cancer	2.44e-06	7.2e-05	CbGpPWpGaD
Norethindrone—CYP3A4—Metabolism—MTR—hematologic cancer	2.44e-06	7.2e-05	CbGpPWpGaD
Norethindrone—PGR—Signaling Pathways—KRAS—hematologic cancer	2.44e-06	7.19e-05	CbGpPWpGaD
Norethindrone—ALB—Metabolism—MTHFR—hematologic cancer	2.42e-06	7.14e-05	CbGpPWpGaD
Norethindrone—ABCB1—Metabolism—GSTM1—hematologic cancer	2.4e-06	7.08e-05	CbGpPWpGaD
Norethindrone—ABCB1—Metabolism—NCOR1—hematologic cancer	2.4e-06	7.08e-05	CbGpPWpGaD
Norethindrone—CYP3A4—Metabolism—ENO2—hematologic cancer	2.4e-06	7.06e-05	CbGpPWpGaD
Norethindrone—CYP3A5—Metabolism—PIK3CG—hematologic cancer	2.36e-06	6.96e-05	CbGpPWpGaD
Norethindrone—ALB—Hemostasis—PIK3CA—hematologic cancer	2.35e-06	6.91e-05	CbGpPWpGaD
Norethindrone—CYP3A4—Metabolism—GSTT1—hematologic cancer	2.32e-06	6.85e-05	CbGpPWpGaD
Norethindrone—CYP3A4—Metabolism—SDC1—hematologic cancer	2.27e-06	6.69e-05	CbGpPWpGaD
Norethindrone—ALB—Hemostasis—TP53—hematologic cancer	2.27e-06	6.68e-05	CbGpPWpGaD
Norethindrone—PGR—Signaling Pathways—PIK3CA—hematologic cancer	2.24e-06	6.61e-05	CbGpPWpGaD
Norethindrone—CYP3A5—Metabolism—CREBBP—hematologic cancer	2.19e-06	6.46e-05	CbGpPWpGaD
Norethindrone—CYP2C19—Metabolism—MTHFR—hematologic cancer	2.18e-06	6.41e-05	CbGpPWpGaD
Norethindrone—PGR—Signaling Pathways—TP53—hematologic cancer	2.17e-06	6.39e-05	CbGpPWpGaD
Norethindrone—ALB—Hemostasis—HRAS—hematologic cancer	2.17e-06	6.39e-05	CbGpPWpGaD
Norethindrone—CYP3A7—Metabolism—PTEN—hematologic cancer	2.17e-06	6.38e-05	CbGpPWpGaD
Norethindrone—ALB—Metabolism of lipids and lipoproteins—PIK3CA—hematologic cancer	2.14e-06	6.29e-05	CbGpPWpGaD
Norethindrone—ABCB1—Metabolism—MTHFR—hematologic cancer	2.12e-06	6.25e-05	CbGpPWpGaD
Norethindrone—CYP3A5—Metabolism—PIK3CD—hematologic cancer	2.08e-06	6.12e-05	CbGpPWpGaD
Norethindrone—PGR—Signaling Pathways—HRAS—hematologic cancer	2.08e-06	6.12e-05	CbGpPWpGaD
Norethindrone—CYP3A7—Metabolism—EP300—hematologic cancer	2.06e-06	6.08e-05	CbGpPWpGaD
Norethindrone—CYP3A5—Metabolism—ALB—hematologic cancer	2.05e-06	6.04e-05	CbGpPWpGaD
Norethindrone—ALB—Metabolism—PIK3CG—hematologic cancer	2.04e-06	6e-05	CbGpPWpGaD
Norethindrone—PGR—Signaling Pathways—IL6—hematologic cancer	1.99e-06	5.85e-05	CbGpPWpGaD
Norethindrone—CYP3A5—Metabolism—PIK3R1—hematologic cancer	1.96e-06	5.78e-05	CbGpPWpGaD
Norethindrone—CYP3A4—Metabolism—NQO1—hematologic cancer	1.93e-06	5.69e-05	CbGpPWpGaD
Norethindrone—CYP3A4—Metabolism—CD44—hematologic cancer	1.93e-06	5.69e-05	CbGpPWpGaD
Norethindrone—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CA—hematologic cancer	1.92e-06	5.65e-05	CbGpPWpGaD
Norethindrone—ALB—Hemostasis—AKT1—hematologic cancer	1.92e-06	5.64e-05	CbGpPWpGaD
Norethindrone—ALB—Metabolism—CREBBP—hematologic cancer	1.89e-06	5.56e-05	CbGpPWpGaD
Norethindrone—PGR—Signaling Pathways—AKT1—hematologic cancer	1.83e-06	5.4e-05	CbGpPWpGaD
Norethindrone—CYP2C19—Metabolism—PIK3CG—hematologic cancer	1.83e-06	5.38e-05	CbGpPWpGaD
Norethindrone—CYP3A4—Metabolism—CYCS—hematologic cancer	1.83e-06	5.38e-05	CbGpPWpGaD
Norethindrone—CYP3A4—Metabolism—HSP90AA1—hematologic cancer	1.82e-06	5.35e-05	CbGpPWpGaD
Norethindrone—CYP3A5—Metabolism—PIK3CB—hematologic cancer	1.81e-06	5.34e-05	CbGpPWpGaD
Norethindrone—ALB—Metabolism—PIK3CD—hematologic cancer	1.79e-06	5.27e-05	CbGpPWpGaD
Norethindrone—ABCB1—Metabolism—PIK3CG—hematologic cancer	1.78e-06	5.25e-05	CbGpPWpGaD
Norethindrone—CYP2C19—Metabolism—CREBBP—hematologic cancer	1.69e-06	4.99e-05	CbGpPWpGaD
Norethindrone—ALB—Metabolism—PIK3R1—hematologic cancer	1.69e-06	4.98e-05	CbGpPWpGaD
Norethindrone—ABCB1—Metabolism—CREBBP—hematologic cancer	1.65e-06	4.87e-05	CbGpPWpGaD
Norethindrone—CYP3A4—Metabolism—GSTP1—hematologic cancer	1.61e-06	4.74e-05	CbGpPWpGaD
Norethindrone—CYP2C19—Metabolism—PIK3CD—hematologic cancer	1.61e-06	4.73e-05	CbGpPWpGaD
Norethindrone—CYP2C19—Metabolism—ALB—hematologic cancer	1.59e-06	4.67e-05	CbGpPWpGaD
Norethindrone—ABCB1—Metabolism—PIK3CD—hematologic cancer	1.57e-06	4.62e-05	CbGpPWpGaD
Norethindrone—CYP3A5—Metabolism—PTEN—hematologic cancer	1.57e-06	4.61e-05	CbGpPWpGaD
Norethindrone—ALB—Metabolism—PIK3CB—hematologic cancer	1.56e-06	4.6e-05	CbGpPWpGaD
Norethindrone—ABCB1—Metabolism—ALB—hematologic cancer	1.55e-06	4.56e-05	CbGpPWpGaD
Norethindrone—CYP3A7—Metabolism—PIK3CA—hematologic cancer	1.53e-06	4.5e-05	CbGpPWpGaD
Norethindrone—CYP3A4—Metabolism—ABCB1—hematologic cancer	1.52e-06	4.49e-05	CbGpPWpGaD
Norethindrone—CYP2C19—Metabolism—PIK3R1—hematologic cancer	1.52e-06	4.47e-05	CbGpPWpGaD
Norethindrone—CYP3A5—Metabolism—EP300—hematologic cancer	1.49e-06	4.4e-05	CbGpPWpGaD
Norethindrone—ABCB1—Metabolism—PIK3R1—hematologic cancer	1.48e-06	4.36e-05	CbGpPWpGaD
Norethindrone—CYP3A4—Metabolism—GSTM1—hematologic cancer	1.48e-06	4.36e-05	CbGpPWpGaD
Norethindrone—CYP3A4—Metabolism—NCOR1—hematologic cancer	1.48e-06	4.36e-05	CbGpPWpGaD
Norethindrone—CYP2C19—Metabolism—PIK3CB—hematologic cancer	1.4e-06	4.13e-05	CbGpPWpGaD
Norethindrone—ABCB1—Metabolism—PIK3CB—hematologic cancer	1.37e-06	4.03e-05	CbGpPWpGaD
Norethindrone—ALB—Metabolism—PTEN—hematologic cancer	1.35e-06	3.97e-05	CbGpPWpGaD
Norethindrone—CYP3A4—Metabolism—MTHFR—hematologic cancer	1.31e-06	3.85e-05	CbGpPWpGaD
Norethindrone—ALB—Metabolism—EP300—hematologic cancer	1.29e-06	3.79e-05	CbGpPWpGaD
Norethindrone—CYP3A7—Metabolism—AKT1—hematologic cancer	1.25e-06	3.68e-05	CbGpPWpGaD
Norethindrone—CYP2C19—Metabolism—PTEN—hematologic cancer	1.21e-06	3.56e-05	CbGpPWpGaD
Norethindrone—ABCB1—Metabolism—PTEN—hematologic cancer	1.18e-06	3.48e-05	CbGpPWpGaD
Norethindrone—CYP2C19—Metabolism—EP300—hematologic cancer	1.15e-06	3.4e-05	CbGpPWpGaD
Norethindrone—ABCB1—Metabolism—EP300—hematologic cancer	1.13e-06	3.32e-05	CbGpPWpGaD
Norethindrone—CYP3A5—Metabolism—PIK3CA—hematologic cancer	1.1e-06	3.25e-05	CbGpPWpGaD
Norethindrone—CYP3A4—Metabolism—PIK3CG—hematologic cancer	1.1e-06	3.24e-05	CbGpPWpGaD
Norethindrone—CYP3A4—Metabolism—CREBBP—hematologic cancer	1.02e-06	3e-05	CbGpPWpGaD
Norethindrone—CYP3A4—Metabolism—PIK3CD—hematologic cancer	9.66e-07	2.85e-05	CbGpPWpGaD
Norethindrone—CYP3A4—Metabolism—ALB—hematologic cancer	9.54e-07	2.81e-05	CbGpPWpGaD
Norethindrone—ALB—Metabolism—PIK3CA—hematologic cancer	9.51e-07	2.8e-05	CbGpPWpGaD
Norethindrone—CYP3A4—Metabolism—PIK3R1—hematologic cancer	9.12e-07	2.69e-05	CbGpPWpGaD
Norethindrone—CYP3A5—Metabolism—AKT1—hematologic cancer	9.02e-07	2.66e-05	CbGpPWpGaD
Norethindrone—CYP2C19—Metabolism—PIK3CA—hematologic cancer	8.54e-07	2.51e-05	CbGpPWpGaD
Norethindrone—CYP3A4—Metabolism—PIK3CB—hematologic cancer	8.42e-07	2.48e-05	CbGpPWpGaD
Norethindrone—ABCB1—Metabolism—PIK3CA—hematologic cancer	8.33e-07	2.45e-05	CbGpPWpGaD
Norethindrone—ALB—Metabolism—AKT1—hematologic cancer	7.77e-07	2.29e-05	CbGpPWpGaD
Norethindrone—CYP3A4—Metabolism—PTEN—hematologic cancer	7.28e-07	2.14e-05	CbGpPWpGaD
Norethindrone—CYP2C19—Metabolism—AKT1—hematologic cancer	6.97e-07	2.05e-05	CbGpPWpGaD
Norethindrone—CYP3A4—Metabolism—EP300—hematologic cancer	6.94e-07	2.04e-05	CbGpPWpGaD
Norethindrone—ABCB1—Metabolism—AKT1—hematologic cancer	6.81e-07	2.01e-05	CbGpPWpGaD
Norethindrone—CYP3A4—Metabolism—PIK3CA—hematologic cancer	5.13e-07	1.51e-05	CbGpPWpGaD
Norethindrone—CYP3A4—Metabolism—AKT1—hematologic cancer	4.19e-07	1.24e-05	CbGpPWpGaD
